Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Methylprednisolone Acetate(Depo-Medrate) has the ability to inhibit oxygen free radicals and can be used to treat acute spinal cord injuries.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | お問い合わせ | ¥ 9,000 |
50 mg | お問い合わせ | ¥ 15,500 |
100 mg | お問い合わせ | ¥ 22,000 |
500 mg | お問い合わせ | ¥ 52,000 |
説明 | Methylprednisolone Acetate(Depo-Medrate) has the ability to inhibit oxygen free radicals and can be used to treat acute spinal cord injuries. |
In vivo | Typical features of early avascular necrosis (AVN) of the femoral head are induced by the combination of intramuscular injection of Methylprednisolone Acetate (30 mg/kg) and additional oral doses of 13 mg/kg for 10 consecutive days with LPS[1] |
別名 | Depo-Medrate, Depometicort, Depo-Medrin, Depo-medrol, Depomedrone, Lemod |
分子量 | 416.51 |
分子式 | C24H32O6 |
CAS No. | 53-36-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Soluble
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Methylprednisolone Acetate 53-36-1 Immunology/Inflammation Metabolism NF-Κb Reactive Oxygen Species Depo-Medrate Depometicort Depo-Medrin Depo-medrol Depomedrone Lemod Inhibitor inhibitor inhibit